EMA — authorised 22 March 2017
- Marketing authorisation holder: PFIZER EUROPE MA EEIG
- Status: approved
🇪🇺 Xeljanz in European Union
EMA authorised Xeljanz on 22 March 2017
Marketing authorisation
Xeljanz in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Immunology approved in European Union
Frequently asked questions
Is Xeljanz approved in European Union?
Yes. EMA authorised it on 22 March 2017.
Who is the marketing authorisation holder for Xeljanz in European Union?
PFIZER EUROPE MA EEIG holds the EU marketing authorisation.